Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

This week's Indian stock market performance hinges on Q1 2025-26 earnings releases from major companies like HDFC Bank, Reliance Industries, and ICICI Bank, along with the outcome of ongoing US-India ...

A trio of industry leaders with well-defined catalysts and competitive advantages can surpass Wall Street's artificial intelligence (AI) darlings over the next decade.

In contrast to prior economic downshifts, overall corporate financial health still appears strong: Profit margins and cash ...

On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its ...

Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...

The average brokerage recommendation (ABR) for Lilly (LLY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

Company touted Kisqali's "replacement power" as another blockbuster faces generic competition and expressed optimism about ...

Due to Tesla's innovation and diversification, 24/7 Wall St. sees strong upside potential for the stock by the end of the decade.

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...